Clinical Trials featured in Financial Times’ Sifted

Between 4-6th December 2023 Decorte Future Industries completed the first phase of its canine clinical trials at a cardiovascular veterinary hospital in Belgium, testing its maverick idea of supplementing AI for human health trained on human data with canine data, in order to increase accuracy for human diagnostics. These trials were featured in the Financial Times’ Sifted on the 6th of December.

The participants were pet dogs who, by simply holding a microphone against their fur, received an additional cardiovascular health check-up as part of their normal veterinary visit.

Based on the idea that human cardiovascular structures are extremely similar to that of dogs, and the fact that much of human medicine has already historically been informed by animal (and specifically canine) medicine, the trials attempt to prove that these principles holds true for training artificial intelligence for human health as well.

Data is always the hardest-to-obtain and most expensive asset for any AI, and even trickier for AI intended to assist with human health, which so far always had to be trained on human medical data. The Decorte canine trials are an attempt to completely rewrite the data-gathering landscape for such AI through a hack which, if successful, will give Decorte the keys to move much faster than any other player in the field.

At the end of the trials, the company will hold the most extensive dataset of canine data for automatic auscultation in the world.